Table 5.
mTBI no follow-up | mTBI with follow-up | p | |
---|---|---|---|
N | 6 | 19 | |
Male # (%) | 5 (80) | 13 (69) | 0.64 |
Age μ (±SD) | 39.5 (±17.7) | 43.7 (±16.35) | 0.59 |
Mean days after trauma μ (±SD) | 59.7 (±36.12) | 64.9 (±45.57) | 0.79 |
SSS | 37 (±14.9) | 35.3 (±27.6) | 0.88 |
SCAT2 | 73.3 (±14.7) | 72.6 (±9.94) | 0.88 |
WM CVR | 0.14 (±0.08) | 0.15 (±0.04) | 0.52 |
GM CVR | 0.24 (±0.16) | 0.26 (±0.066) | 0.66 |
Brain CVR | 0.19 (±0.11) | 0.20 (±0.01) | 0.58 |
WM volume | 423.3 (±55.5) | 410.8 (±47.7) | 0.59 |
GM volume | 364.3 (±67.15) | 365.4 (±41.7) | 0.96 |
This table is included to highlight the homogeneity within the sample of TBI patients. The subset of six patients who were not able to complete a follow-up MRI or clinic visit show comparable values on symptom scores and imaging indices. These comparisons examine the data collected at visit 1 only.